Neurosciences

Transgender Hormone Therapy: Plasma Proteome Changes

by

Significant Protein Shifts Observed During Gender-Affirming Hormone Therapy Groundbreaking research has revealed substantial alterations in the protein composition of blood plasma among individuals undergoing feminizing gender-affirming hormone therapy. A new study, detailed in Nature Medicine, identifies nearly 300 proteins that experience significant changes over a six-month period, potentially impacting long-term health outcomes. Understanding the Biological … Read more

SARS-CoV-2 DNA Antibody Safety & PK in Adults – Phase 1

by

Promising New Approach to COVID-19 Protection: Intramuscular Antibody Delivery Shows Safety in Early Trials In a significant step forward in the ongoing fight against COVID-19, a phase 1 clinical trial has demonstrated the safety and tolerability of a novel approach to delivering protective antibodies directly into the body. Researchers have successfully tested intramuscular injections of … Read more

Alzheimer’s: Quick Cognitive Test Boosts Early Detection

by

New Digital Test Dramatically Improves Alzheimer’s Diagnosis Accuracy A groundbreaking new assessment tool, BioCog, is poised to revolutionize the early detection of cognitive decline, offering hope for more timely and effective interventions for individuals at risk of neurodegenerative diseases like Alzheimer’s. The innovative digital test battery, designed for brief self-administration in primary care settings, has … Read more

Domvanalimab & Zimberelimab: Gastric/Esophageal Cancer Trial

by

Promising New Drug Combination Shows Benefit in Advanced Cancers In a significant development for cancer treatment, a novel combination therapy is demonstrating encouraging results in patients battling advanced gastric, gastroesophageal junction, and esophageal cancers. The treatment regimen, featuring domvanalimab and zimberelimab alongside standard FOLFOX chemotherapy, was presented at the ESMO Congress 2025 and detailed in … Read more

Nivolumab & Relatlimab: Melanoma Stage III/IV Trial Results

by

Melanoma Treatment Combination Shows No Significant Survival Benefit in Late-Stage Trials Recent findings from the RELATIVITY-098 trial, presented at both the ASCO 2025 Annual Meeting and the ESMO Congress 2025, indicate that adding relatlimab to nivolumab does not significantly improve recurrence-free survival in patients with stage III or IV resected melanoma. This news represents a … Read more

MC4R Obesity: Lower Cholesterol & Heart Risk?

by

Obesity Linked to MC4R Deficiency May Offer Unexpected Cardiovascular Protection Groundbreaking research published today reveals a surprising connection between obesity caused by a deficiency in the melanocortin 4 receptor (MC4R) and a reduced risk of cardiovascular disease. The findings, stemming from analysis of two extensive population cohorts, challenge conventional wisdom surrounding obesity and heart health. … Read more

Cancer End-of-Life: Tumor Spread & Circulating Cells

by

Spike in Circulating Tumor Cells Linked to Cancer Mortality New research reveals a critical biological event occurring in the final stages of cancer: a dramatic surge in circulating tumor cell clusters (CTCs) coinciding with the time of death. This finding, coupled with evidence of tumor cells invading major blood vessels, offers a potential new understanding … Read more

Oocyte & Embryo Defects: Genes & Female Infertility

by

Genetic Factors Linked to IVF Failure: New Research Offers Hope for Improved Fertility Treatments A groundbreaking study has identified specific genetic variations that may contribute to unsuccessful in vitro fertilization (IVF) cycles, offering a potential pathway toward more personalized and effective fertility treatments. Researchers analyzed the genetic makeup of over 2,140 women experiencing recurrent IVF … Read more

Rotavirus Vaccine: Fewer Hospitalizations for Indian Kids

by

Rotavac Vaccine Demonstrates Strong Effectiveness Against Childhood Gastroenteritis in India New research reveals significant protection offered by Rotavac, an indigenous rotavirus vaccine, in preventing severe diarrheal illness among young children in India. The findings, stemming from a comprehensive observational study, bolster confidence in the vaccine’s role in public health initiatives aimed at reducing the burden … Read more

Budigalimab & HIV: PD-1 Blockade Safety & Early Effects

by

Budigalimab Shows Promise in Delaying HIV Viral Rebound During Treatment Interruption In a significant development for HIV research, a new study indicates that the experimental drug budigalimab may offer a novel approach to controlling the virus. Early trial results reveal that budigalimab, a PD-1 inhibitor, was well-tolerated by participants and demonstrated the ability to delay … Read more

© 2026 Archyworldys. All rights reserved.

For contact, advertising, copyright, issues email: [email protected]